Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2022-03-23 00:00:00 ET · period of report 2022-03-21 · accession 0001415889-22-003286 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-23 | 2022-03-21 | KNSA | Moat Ross | Chief COMMERCIAL Off | M - OptEx | — | +2,270 | 8,612 | +36% | — |
| D | 2022-03-23 | 2022-03-21 | KNSA | Moat Ross | Chief COMMERCIAL Off | F - Tax | $10.98 | -1,240 | 7,372 | -14% | -$13.6K |
| D | 2022-03-23 | 2022-03-21 | KNSA | Moat Ross | Chief COMMERCIAL Off | M - OptEx | $0.00 | -2,270 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Share | 2022-03-21 | M | A | 2,270 | — | 8,612 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. |
| 2 | Common | Class A Common Share | 2022-03-21 | F | D | 1,240 | $10.98 | 7,372 | D | — | — | |
| 3 | Derivative | Restricted Share Unit | 2022-03-21 | M | D | 2,270 | $0.00 | 0 | D | — · — to — | 2,270 Class A Common Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. (F2) The performance criteria for these RSUs were met. The RSUs vested in a single installment on March 20, 2022; there was no expiration date for the RSUs. |